Global Cell Isolation/Cell Separation Market

Cell Isolation/Cell Separation Market Size, Share, Growth Analysis, By Product(Consumables, Instrument), By Cell Type(Animal Cells, Human Cells), By Technique(Centrifugation, Surface Marker, Filtration), By Cell Source(Bone Marrow, Adipose tissue, Cord blood/Embryonic stem cells), By Application(Biomolecule Isolation, Cancer Research, Stem Cell Research, Tissue Regeneration), By End Use(Research Laboratories & Institutes, Biotechnology & Biopharmaceutical Companies, Hospital & Diagnostic Laboratories, Cell Banks), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35H2169 | Region: Global | Published Date: February, 2024
Pages: 157 | Tables: 173 | Figures: 71

Cell Isolation/Cell Separation Market Dynamics

Cell Isolation/Cell Separation Market Drivers

Increasing prevalence of cancer and emphasis on personalized medicine to drive market growth

  • The primary driver for market expansion is the rise in number of cancer infected patients. The market is also anticipated to develop as a result of rise in government support for cell-based research, and a growing emphasis on customised treatment, and technical advancements. 
  • The market is also driven by the rising investments in cell biology research and the expanding presence of market participants in developing nations. Use of a number of cutting-edge tools and approaches is anticipated to boost the market expansion as a result of rising R&D activity in the pharmaceutical and biotechnology sectors. Additionally, the projected rise in biotech research and development activities would significantly raise the need for cell isolation kits and other separation tools
  • The growing focus on producing personalized medicine is projected to result in efficiency and reliable cell-isolation technologies. Also, the growing prevalence of isolated therapies is on the growing verge thereby triggering the need for personalized medicine.

Cell Isolation/Cell Separation Market Restraints

High Cost Associated with Procedures and lack of standardization to hinder market growth

  • Although cell separation equipment and related items can produce precise and efficient results, they are nevertheless crucial tools for scientific study and the detection of diseases. The high cost of these products, however, is one of the main barriers to this industry. Furthermore, techniques for cell separation come with a variety of expenses for equipment, reagents, kits, sera, and services. The setup costs for cell separation are considerable, as are the reagents required for particular applications. During the projected period, these factors are anticipated to limit market growth.
  • The lack of standardization is expected to create hindrances owing to the variations produced in the end results.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Cell Isolation/Cell Separation Market size was valued at USD 2.1 billion in 2019 and is poised to grow from USD 3.2 billion in 2023 to USD 11.6 billion by 2031, growing at a CAGR of 21.8% in the forecast period (2024-2031).

In October 2022, the world's leading provider of scientific services, Thermo Fisher Scientific Inc., unveiled the GibcoTM CTSTM DynaCellectTM Magnetic Separation System (DynaCellect) to make it simple for companies developing cell therapies to transition from process and clinical development to commercial manufacturing. A scalable, adaptable, automated, closed system is provided by this next-generation cell separation, cell activation, cell depletion, and DynabeadsTM magnetic beads removal apparatus to help optimize the cell therapy manufacturing process. 'Terumo Corporation', 'STEMCELL Technologies Inc.', 'Bio-Rad Laboratories, Inc.', 'Merck KGaA', 'GE Healthcare', 'Miltenyi Biotec', 'pluriSelect Life Science UG & Co. KG', 'Takara Bio Inc', 'EMD Millipore', 'PerkinElmer', 'ZEISS', 'Akadeum Life Sciences'

The primary driver for market expansion is the rise in number of cancer infected patients. The market is also anticipated to develop as a result of rise in government support for cell-based research, and a growing emphasis on customised treatment, and technical advancements. 

Growing use of microfluidic technologies: The use of microfluidic technologies offers a better control for cell flows and fluids resulting in an effective cell separation.

North America accounted for a large market share in 2022. This can be ascribed to the developed pharmaceutical and biotech sectors as well as the widespread use of innovative technology in the United States. There is a big market for cell separation technologies as a result of research universities' extensive activity in the field of cell treatments. Additionally, the growing incidence of chronic and infectious disorders, has increased the need for cell separation technologies for use in both research and therapeutic settings.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Cell Isolation/Cell Separation Market

Report ID: SQMIG35H2169

$5,300
BUY NOW GET FREE SAMPLE